Washington, D.C., (August 5, 2004) — Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

Genomic studies have placed a comprehensive understanding of pathogenesis in sight, but much work lies ahead, according to the report, The Genomics of Disease-Causing Organisms: Mapping a Strategy for Discovery and Defense. The report is based on the findings of a colloquium convened by the Academy in Key Largo, Florida, in November 2003. Professionals in the fields of genomics, bacteriology, virology, eukaryotic microbiology, medicine, clinical diagnostics, bioinformatics and forensics participated in discussions on the recent advancements in the field and the outlook for future research.

"Genomics has had a profound and lasting impact on the study of pathogens and disease, to the extent that it is difficult to imagine what the science would be like today in the absence of genomics," says Richard J. Roberts, Chair of the Colloquium Steering Committee. "Today a genome sequence is the first priority when investigating an emerging infectious disease, and vaccines and therapies are often designed straight from the genome."

Since the first completed genome of a pathogenic bacterium was announced in 1995, over 100 bacterial pathogens and over 1,000 viruses have been sequenced. These genomes have led to revolutions in disease research. For example, genome data can help to globally track and identify existing and new diseases, such as in the case of SARS. Genomics has identified the genetic signatures that today are being used in bioforensics to allow authorities to investigate cases of suspected bioterrorism. Some of the recent drugs in the arsenal again
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
5-Aug-2004

Page: 1 2
Related biology news :

1. Veterinary Memorial Fund transforms grief into promise
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
4. Proteins show promise for mosquito control
5. New drug shows promise against Gleevec resistance in mice
6. Basic RNA enzyme research promises single-molecule biosensors
7. Targeted therapy for lung cancer patients shows promise in extending lives
8. Protein stops blood-vessel growth, holds promise as cancer therapy
9. Natural, man-made mix promises biggest landscape plant growth
10. Lowly weeds may hold promise for curing host of common health woes
11. Susceptibility of mice to mousepox offers promise of smallpox protection